Rivaroxaban - Open Access .click

Results 111 to 120 of about 44,637 (214)

A comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk

Frontiers in Cardiovascular Medicine
ObjectiveRivaroxaban and dabigatran are approved to reduce the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF). However, the clinical benefits of rivaroxaban and dabigatran in people with high bleeding risk are unclear.MethodsA ...
Penghui Liu
doaj +1 more source

PENGARUH PEMBERIAN RIVAROXABAN TERHADAP PENURUNAN INSIDENSI DEEP VEIN THROMBOSIS (DVT) PASCA OPERASI TOTAL KNEE REPLACEMENT (TKR) DI RSUD DR. ZAINOEL ABIDIN BANDA ACEH [PDF]

, 2017
Deep Vein Thrombosis (DVT) merupakan gumpalan darah (trombus) yang terbentuk pada vena didalam tubuh yang memungkinkan terjadinya gangguan sirkulasi dan memblokir aliran darah ke paru-paru serta dapat menyebabkan kerusakan permanen pada katup pembuluh ...
Dian Wathani
core

Assessing the link between rivaroxaban concentration and the onset of renal impairment in elderly patients: A retrospective observational study

Asian Journal of Medical Sciences
Background: Rivaroxaban is a widely used anticoagulant, but its impact on renal function, particularly at varying plasma concentrations, remains a critical area of investigation.
Motakatla Usha Rani +2 more
doaj +1 more source

Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up

Medicina
Background and Objectives: Rivaroxaban is a direct-acting anticoagulant used to prevent stroke in patients with atrial fibrillation. Rivaroxaban is a substrate for P-glycoprotein, which is encoded by the ABCB1 gene. Rivaroxaban is also metabolized by the
Nur Ul Ain +4 more
doaj +1 more source

Rivaroxaban for prevention of VTE [PDF]